Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 7,882 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Palliative Care Referral, Advanced Cancer, Palliative Care, Health Services, Metastatic Cancer (Different Solid Tumour Types)
Interventions: ePRO-Directed Referral and Navigation to Palliative/Supportive Care, ePRO Symptom Monitoring with Usual Palliative Care Referral; Behavioral · Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Pregnancy, Obesity, Overweight
Interventions: No Intervention; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 2,701 participants
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Princeton, New Jersey

Conditions: Diabetic Foot Ulcer, Osteomyelitis Chronic
Interventions: Borate-base Bioactive Glass Fiber Matrix (BBGFM); Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Rhinitis Allergic, Persistent
Interventions: Not listed
Lead sponsor: UCB Pharma; Industry
Eligibility: 2 Years and older
Enrollment: 7,870 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Smyrna, Georgia

Conditions: Alcohol Dependence
Interventions: Acamprosate; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8
Interventions: Carboplatin, Cisplatin, Computed Tomography, Durvalumab, Etoposide, Image Guided Radiation Therapy, Nab-paclitaxel, Osimertinib, Paclitaxel, Pemetrexed, Positron Emission Tomography, Questionnaire Administration, Stereotactic Body Radiation Therapy; Drug · Procedure · Biological + 2 more
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 476
States / cities: Birmingham, Alabama • Daphne, Alabama • Fairhope, Alabama + 357 more

Conditions: Cardiovascular Risk Factor, Circadian Dysregulation, Obesity
Interventions: Positron Emission Tomography (PET) scanning of cardiac function at 3 time points across the 24 hour circadian cycle; Combination Product
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 25 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2
Interventions: No intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Atrial Fibrillation
Interventions: Dronedarone; Drug
Lead sponsor: American Heart Association; Other
Eligibility: 21 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 103
States / cities: Fairhope, Alabama • Gilbert, Arizona • Scottsdale, Arizona + 78 more

Conditions: Musculoskeletal Disorders, Stress Management, Perceived Stress, Reported Stress, Perceived Pain, Reported Pain
Interventions: Barre Stretching Intervention; Behavioral
Lead sponsor: Idaho State University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Pocatello, Idaho

Conditions: Concussion, Mild
Interventions: Pro2Cool Device, Sham Cooling Garment Device; Device
Lead sponsor: TecTraum Inc.; Industry
Eligibility: 13 Years to 21 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Ann Arbor, Michigan • Akron, Ohio • Cleveland, Ohio

Conditions: Obesity &Amp;Amp;Amp; Overweight, Environmental Exposure, Overweight (BMI > 25)
Interventions: Educational curriculum, Weight loss Application, Urinary EDC metabolite testing, Siphox clinic biomarker test, Weight loss reporting; Behavioral · Diagnostic Test
Lead sponsor: Million Marker Wellness, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Behavior Problem, Behavior, Child, Parents, Parent-Child Relations
Interventions: Communication Skills Training, eHealth GenPMTO, Written Referral Process, One Session Education about Resources, Survey of Experience; Behavioral · Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 16 Years to 100 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Head and Neck Cancer
Interventions: Cone Beam Computed Tomography (CT) Scan; Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Renal Cell Carcinoma
Interventions: Sunitinib, Nephrectomy; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2026
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Weight Bias
Interventions: BRAVE, SOL: Standard Obesity Lecture; Behavioral
Lead sponsor: Villanova University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 368 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Villanova, Pennsylvania

Conditions: Burns, Liver Fibroses, Pancreas Disease, Thyroid Diseases
Interventions: Ultrasound/transient elastography; Device
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 6 Months and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mature B-Cell Lymphoma
Interventions: COPAD, COP, COPD M3, CYM, COP, COPADM8, CYVE; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 2
States / cities: San Diego, California • Memphis, Tennessee

Conditions: Japanese Encephalitis
Interventions: Blood draw, IC51 has given in the parent study IC51-322; Procedure · Biological
Lead sponsor: Valneva Austria GmbH; Industry
Eligibility: 9 Months to 20 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Obesity, Non-Alcoholic Fatty Liver Disease
Interventions: Blood Draw, Stool collection, BodPod Measurement, Liver Ultrasound; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Renal Cell Carcinoma
Interventions: CyberKnife; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metastatic Solid Cancers, Colorectal Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Gastrointestinal Cancer, Ovarian Cancer, Genitourinary Cancer
Interventions: Aldesleukin, Fludarabine, Cyclophosphamide, KRAS TCR-Transduced PBL, GRT-C903/GRT-R904; Drug · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 72 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Irritable Bowel Syndrome (IBS), Functional Abdominal Pain, Fibromyalgia, Complex Regional Pain Syndrome (CRPS), Myofacial Pain, Chronic Daily Headaches, Migraine Headaches, Chronic Pain
Interventions: Mentorship; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 18 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Opioid-use Disorder, Opioid-related Disorders
Interventions: Not applicable - no defined intervention; Other
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 534 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 35
States / cities: Haleyville, Alabama • Hamilton, Alabama • Little Rock, Arkansas + 30 more

Search by objective public record fields.

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Mirragen Diabetic Foot Ulcer Study

Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study

Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Body Weight, Sleep, and Heart Health

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Diabetes Mellitus

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Impact of Barre Stretching Among Dental Hygiene Students

Pro-2-Cool Pivotal Trial II

Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity

Effectiveness of an Online Parenting Training

A Study Using Cone Beam CT for Head and Neck Cancer

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study

Liver, Pancreas and Thyroid Function in Burn Patients

Mature B-Cell Lymphoma And Leukemia Study III

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Evaluation of Intestinal Microbiome in Obese Kids

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents

An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery